Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Amrize Ltd

CIK 2035989Updated Sep 24, 2026

Name history
Evertect AG · through Jan 10, 2025

AMRZ price & chart

Provider market data

Loading TradingView…

NYSE:AMRZ on TradingView ↗

TradingView · Data may be delayed

About the company

Amrize (NYSE: AMRZ) is building North America, as the partner of choice for professional builders with advanced branded solutions from foundation to rooftop. With over 1,000 sites and a highly efficient distribution network, we deliver for our customers in every U.S. state and Canadian province. Our 19,000 teammates uniquely serve every construction market from infrastructure, commercial and residential to new build, repair and refurbishment. Amrize achieved $11.8 billion in revenue in 2025 and is listed on the New York Stock Exchange and the SIX Swiss Exchange. We are ready to build your ambition. Learn more at amrize.com

8-K · 2026-09-11 · 0001140361-26-036349

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Financials

FY 2025 · USD
Revenue11,815,000,000USD · FY 2025
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

Net income1,185,000,000USD · FY 2025
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

Operating income1,906,000,000USD · FY 2025
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

Diluted EPS2.14USD per share · FY 2025
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024
ASSETS
AssetsUSD24,249,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

23,805,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

GoodwillUSD9,020,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

8,917,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Intangible Assets, Net (Excluding Goodwill)USD1,728,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

1,832,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD1,922,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

1,585,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Inventory, NetUSD1,551,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

1,452,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Assets, CurrentUSD4,681,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

4,781,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Prepaid Expense and Other Assets, CurrentUSD88,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

143,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Operating Lease, Right-of-Use AssetUSD608,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

547,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Other Assets, NoncurrentUSD277,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

194,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD10,995,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

13,891,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD6,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

0
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Additional Paid in CapitalUSD12,741,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

0
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Retained Earnings (Accumulated Deficit)USD902,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

0
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-391,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

-606,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Stockholders' Equity Attributable to ParentUSD13,258,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

9,915,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Liabilities and EquityUSD24,249,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

23,805,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Current liabilities:
Liabilities, CurrentUSD2,857,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

2,550,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Operating Lease, Liability, CurrentUSD136,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

149,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Operating Lease, Liability, NoncurrentUSD500,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

386,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Deferred Income Tax Liabilities, NetUSD1,048,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

936,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Other Liabilities, NoncurrentUSD1,654,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

1,521,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Stockholders' Equity Attributable to Noncontrolling InterestUSD-4,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

-1,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Additional Financial Items
Deferred Tax Liabilities, NetUSD1,028,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

936,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2024-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025FY 2024
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD1,182,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

1,273,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD758,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

736,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD14,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

6,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD43,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-211,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Increase (Decrease) in InventoriesUSD61,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

146,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Deferred Income Tax Expense (Benefit)USD78,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-35,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD2,208,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

2,282,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Cash flows from investing activities:
Payments to Acquire Businesses, Net of Cash AcquiredUSD86,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

249,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Net Cash Provided by (Used in) Investing ActivitiesUSD-361,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-1,208,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Payments for (Proceeds from) Other Investing ActivitiesUSD52,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

27,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Payments to Acquire Property, Plant, and EquipmentUSD788,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

642,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD-1,555,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-537,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Proceeds from (Payments for) Other Financing ActivitiesUSD-3,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-8,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD337,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

478,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD1,922,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

1,585,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD411,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

497,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Income Taxes Paid, NetUSD369,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

302,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD14,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

0
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Amortization of Intangible AssetsUSD142,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

139,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Asset Retirement Obligation, Accretion ExpenseUSD14,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

14,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD15,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

71,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

GoodwillUSD9,020,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

As of 2025-12-31

8,917,000,000
Source

10-Q · 2025-08-07 · 0002035989-25-000004

As of 2024-12-31

Income (Loss) from Equity Method InvestmentsUSD11,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

13,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Income Tax Expense (Benefit)USD326,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

368,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

InterestExpenseNonoperatingUSD461,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

547,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Investment Income, InterestUSD48,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

35,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Net Income (Loss) Attributable to ParentUSD1,185,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

1,274,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD-3,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-1,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Other Nonoperating Income (Expense)USD4,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-55,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Pension Expense (Reversal of Expense), NoncashUSD12,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

71,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024
Total RevenueUSD11,815,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

11,704,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Cost of RevenueUSD8,781,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

8,634,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Selling, General and Administrative ExpenseUSD1,128,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

944,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Operating Income (Loss)USD1,906,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

2,195,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Other Nonoperating Income (Expense)USD4,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-55,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Income Tax Expense (Benefit)USD326,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

368,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD-3,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-1,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Net Income (Loss) Attributable to ParentUSD1,185,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

1,274,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Earnings Per Share, BasicUSD per share2.14
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

2.3
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Earnings Per Share, DilutedUSD per share2.14
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

2.3
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Weighted Average Number of Shares Outstanding, Basicshares553,100,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

553,100,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares553,600,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

553,100,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Interest Expense (non-operating)USD461,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

547,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Additional Financial Items
Amortization of Intangible AssetsUSD142,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

139,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Current Income Tax Expense (Benefit)USD248,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

403,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Depreciation, Depletion and Amortization, NonproductionUSD914,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

889,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Gross ProfitUSD3,034,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

3,070,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD288,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

328,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Income (Loss) from Equity Method InvestmentsUSD11,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

13,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Interest Expense, DebtUSD216,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

43,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Interest Income (Expense), Nonoperating, NetUSD-413,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

-512,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Investment Income, InterestUSD48,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

35,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Marketing and Advertising ExpenseUSD45,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2025-01-01 to 2025-12-31

25,000,000
Source

10-K · 2026-02-18 · 0002035989-26-000017

2024-01-01 to 2024-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ef20081881_ex99-1.htm · 8-K · 2026-09-11

EX-99.1 2 ef20081881_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Media Release Media Release Amrize Appoints Mario Gross as President of Building Envelope CHICAGO & ZUG, Switzerland, September 11, 2026 - The Amrize (NYSE: AMRZ) Board of Directors has appointed Mario Gross as President, Building Envelope, effective September 11, 2026. Gross succeeds Jake Gosa, who is stepping down from the role and is committed to a smooth transition. Gross has been a member of Amrize’s Executive Committee a

8-K · 2026-09-11 · 0001140361-26-036349

Read attachment ↗
ef20080964_ex99-1.htm · 8-K · 2026-08-24

EX-99.1 4 ef20080964_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Media Release Ad hoc announcement pursuant to Art. 53 LR Amrize Appoints Sam Poletti as Chief Financial Officer CHICAGO & ZUG, Switzerland, August 24, 2026 - The Amrize (NYSE: AMRZ) Board of Directors has appointed Samuel J. Poletti as Chief Financial Officer, effective August 24. Poletti succeeds Baris Oran, who is stepping down for personal reasons. The company has also named Dillon Cumming as vice president of Investor Relat

8-K · 2026-08-24 · 0001140361-26-034208

Read attachment ↗
ef20069458_ex99-1.htm · 8-K · 2026-03-31

EX-99.1 3 ef20069458_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Media Release Ad hoc announcement pursuant to Art. 53 LR Amrize Appoints Baris Oran as Chief Financial Officer CHICAGO & ZUG, Switzerland, March 31, 2026 - The Amrize (NYSE: AMRZ) Board of Directors has appointed Baris Oran as Chief Financial Officer and a member of the company’s Executive Committee, effective April 1. Oran succeeds Ian Johnston, who will step down from the role and remain with the company as a senior advisor

8-K · 2026-03-31 · 0001140361-26-012350

Read attachment ↗
ef20050735_ex99-1.htm · 8-K · 2025-06-23

EX-99.1 10 ef20050735_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Amrize Debuts as Independent, Publicly Traded Company 100% spin-off from Holcim complete Amrize begins trading on NYSE and SIX under ticker symbol “AMRZ” Amrize to be the partner of choice for North America’s professional builders NEW YORK and ZURICH, June 23, 2025 - Amrize announces its debut today as an independent, publicly traded company with the completion of its 100% spin-off from Holcim. Amrize shares will begin tra

8-K · 2025-06-23 · 0001140361-25-023352

Read attachment ↗
ef20050701_ex4-1.htm · 8-K · 2025-06-18

EX-4.1 2 ef20050701_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 HOLCIM FINANCE US LLC as Company, AMRIZE LTD, HOLCIM LTD and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee First Supplemental Indenture Dated as of June 18, 2025 3.500% Senior Notes due 2026 4.200% Senior Notes due 2033 7.125% Senior Notes due 2036 6.875% Senior Notes due 2039 6.500% Senior Notes due 2043 4.750% Senior Notes due 2046 TABLE OF CONTENTS

8-K · 2025-06-18 · 0001140361-25-022997

Read attachment ↗
ef20050701_ex4-2.htm · 8-K · 2025-06-18

EX-4.2 3 ef20050701_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 INDENTURE Dated as of Among HOLCIM FINANCE US LLC, AMRIZE LTD, HOLCIM LTD and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee TABLE OF CONTENTS ARTICLE 1 Definitions and Incorporation by Reference Section 1.01. Definitions 1 Section 1.02. Other Definitions 7

8-K · 2025-06-18 · 0001140361-25-022997

Read attachment ↗